IN8bio Inc (INAB)
1.03
+0.01
(+0.98%)
USD |
NASDAQ |
May 17, 16:00
1.03
0.00 (0.00%)
After-Hours: 20:00
IN8bio Price to Book Value: 2.593 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.593 |
| May 16, 2024 | 2.568 |
| May 15, 2024 | 2.845 |
| May 14, 2024 | 2.618 |
| May 13, 2024 | 2.568 |
| May 10, 2024 | 2.543 |
| May 09, 2024 | 2.543 |
| May 08, 2024 | 2.543 |
| May 07, 2024 | 2.543 |
| May 06, 2024 | 2.513 |
| May 03, 2024 | 2.512 |
| May 02, 2024 | 2.562 |
| May 01, 2024 | 2.612 |
| April 30, 2024 | 2.562 |
| April 29, 2024 | 2.487 |
| April 26, 2024 | 2.612 |
| April 25, 2024 | 2.612 |
| April 24, 2024 | 2.662 |
| April 23, 2024 | 2.612 |
| April 22, 2024 | 2.511 |
| April 19, 2024 | 2.587 |
| April 18, 2024 | 2.637 |
| April 17, 2024 | 2.512 |
| April 16, 2024 | 2.421 |
| April 15, 2024 | 2.519 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.742 |
| April 11, 2024 | 2.840 |
| April 10, 2024 | 2.717 |
| April 09, 2024 | 2.692 |
| April 08, 2024 | 2.692 |
| April 05, 2024 | 2.717 |
| April 04, 2024 | 2.766 |
| April 03, 2024 | 2.569 |
| April 02, 2024 | 2.717 |
| April 01, 2024 | 2.840 |
| March 28, 2024 | 2.048 |
| March 27, 2024 | 2.100 |
| March 26, 2024 | 2.170 |
| March 25, 2024 | 2.083 |
| March 22, 2024 | 2.152 |
| March 21, 2024 | 2.170 |
| March 20, 2024 | 2.222 |
| March 19, 2024 | 2.083 |
| March 18, 2024 | 2.135 |
| March 15, 2024 | 1.979 |
| March 14, 2024 | 2.014 |
| March 13, 2024 | 2.170 |
| March 12, 2024 | 2.205 |
| March 11, 2024 | 2.205 |
| March 08, 2024 | 2.257 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.152
Minimum
Nov 21 2022
5.742
Maximum
May 19 2023
2.157
Average
1.951
Median
Price to Book Value Benchmarks
| Jaguar Health Inc | 6.320 |
| Aptevo Therapeutics Inc | 0.5348 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
Price to Book Value Related Metrics
| Price | 1.03 |
| Earnings Yield | -88.35% |
| Market Cap | 45.45M |